SOCS2 and TPD52

  • Number of citations of the paper that reports this interaction (PMID 21988832)
  • 14
  • Data Source:
  • BioGRID (two hybrid)

SOCS2

TPD52

Gene Name suppressor of cytokine signaling 2 tumor protein D52
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Metabolite levels (HVA/MHPG ratio) ( 23319000)
Protein-Protein Interactions 12 interactors: ARFIP2 BMI1 EPOR GHR IGF1R INSR PLA2G1B PRLR PTK2 RYBP SOCS3 TPD52 8 interactors: ANXA6 MAL2 SENP2 SOCS2 SRPK2 TPD52L1 TPD52L2 TPD52L3
Entrez ID 8835 7163
HPRD ID 05490 04963
Ensembl ID ENSG00000120833 ENSG00000076554
Uniprot IDs O14508 P55327
PDB IDs 2C9W 4JGH
Enriched GO Terms of Interacting Partners?
Tagcloud ?
abrogation  adenomas  alcoholic  ccl3  col1a2  col3a1  compromised  confirming  fibrotic  fivefold  gh  ghr  ghrld  hepatic  hyperlipidemia  livers  microscopic  mup1  nafld  proteomics  qpcr  selenbp2  socs3  steatosis  superarray  tgfbeta  threefold  tolerance  unravel 
adjuvant  antigens  autoimmunity  broad  burden  class  considers  demonstrating  efforts  exhibiting  expected  focusing  highlighting  largest  obstacle  oncogenesis  overcome  overexpressed  perhaps  possibly  preclinical  preclude  presumed  promising  shed  subset  tolerance  understudied  vaccine 
Tagcloud (Difference) ?
abrogation  adenomas  alcoholic  ccl3  col1a2  col3a1  compromised  confirming  fibrotic  fivefold  gh  ghr  ghrld  hepatic  hyperlipidemia  livers  microscopic  mup1  nafld  proteomics  qpcr  selenbp2  socs3  steatosis  superarray  tgfbeta  threefold  unravel 
adjuvant  antigens  autoimmunity  broad  burden  class  considers  demonstrating  efforts  exhibiting  expected  focusing  highlighting  largest  obstacle  oncogenesis  overcome  overexpressed  perhaps  possibly  preclinical  preclude  presumed  promising  shed  subset  understudied  vaccine 
Tagcloud (Intersection) ?
tolerance